← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 31, 2014Last known activity
Jun 25, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 4 trials)
Phase 3 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Recent trials (9)
- NCT06489587OfficialN/AJun 25, 2024
- NCT06489587Lead sponsorN/AJun 25, 2024
- NCT06489587Sponsor investigatorN/AJun 25, 2024
- NCT03929575Lead sponsorPhase 3May 1, 2019
- NCT03929575Reponsible party - principal investigatorPhase 3May 1, 2019
- NCT03444922Reponsible party - principal investigatorN/ASep 1, 2016
- NCT03444922Overall official - principal investigatorN/ASep 1, 2016
- NCT03444922Lead sponsorN/ASep 1, 2016
- NCT02120599Study directorN/AMar 31, 2014
Details
- Last known activity
- Jun 25, 2024